Analyst Ratings for GlaxoSmithKline (GSK) [Neutrals]
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/28/2012 | UBS | Downgrade | Neutral (Buy) |
N/A (N/A) |
46.49 | 52.65 | 13.25% | Details |
| 8/13/2012 | Jefferies | Downgrade | Hold (Buy) |
N/A (N/A) |
46.84 | 52.65 | 12.4% | Details |
| 8/10/2012 | Cowen | Downgrade | Neutral (Outperform) |
N/A (N/A) |
46.69 | 52.65 | 12.77% | Details |
| 1/11/2011 | Citi | Downgrade | Neutral (N/A) |
N/A (N/A) |
38.77 | 52.65 | 35.8% | Details |
| 12/7/2010 | Credit Suisse | Upgrade | Neutral (N/A) |
N/A (N/A) |
39.08 | 52.65 | 34.72% | Details |
